Schedule 13G ownership disclosure

Trevi Therapeutics Inc

Security class unavailable · CUSIP: 89532M101

Event date: 2022-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,185,664
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-22-000268
Form type
SC 13G
Filer
Rosalind Advisors, Inc.
CIK
CIK 1622627
Filed
Mar 09, 2022
Reporting period
Feb 28, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub